Taiwan · Delayed Price · Currency is TWD Li Kang Biomedical Statistics
Total Valuation
TPEX:6242 has a market cap or net worth of TWD 1.21 billion. The enterprise value is 1.14 billion.
| Market Cap | 1.21B |
| Enterprise Value | 1.14B |
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
TPEX:6242 has 31.81 million shares outstanding. The number of shares has increased by 2.50% in one year.
| Current Share Class | 31.81M |
| Shares Outstanding | 31.81M |
| Shares Change (YoY) | +2.50% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | n/a |
| Float | 12.62M |
Valuation Ratios
The trailing PE ratio is 14.50.
| PE Ratio | 14.50 |
| Forward PE | n/a |
| PS Ratio | 2.05 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.69, with an EV/FCF ratio of -4.82.
| EV / Earnings | 13.65 |
| EV / Sales | 1.94 |
| EV / EBITDA | 10.69 |
| EV / EBIT | 11.64 |
| EV / FCF | -4.82 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.50 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 1.18 |
| Debt / FCF | -0.53 |
| Interest Coverage | 264.20 |
Financial Efficiency
Return on equity (ROE) is 9.71% and return on invested capital (ROIC) is 9.96%.
| Return on Equity (ROE) | 9.71% |
| Return on Assets (ROA) | 5.77% |
| Return on Invested Capital (ROIC) | 9.96% |
| Return on Capital Employed (ROCE) | 10.63% |
| Weighted Average Cost of Capital (WACC) | 3.64% |
| Revenue Per Employee | 4.83M |
| Profits Per Employee | 687,082 |
| Employee Count | 122 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, TPEX:6242 has paid 20.23 million in taxes.
| Income Tax | 20.23M |
| Effective Tax Rate | 19.44% |
Stock Price Statistics
The stock price has decreased by -7.32% in the last 52 weeks. The beta is -0.05, so TPEX:6242's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -7.32% |
| 50-Day Moving Average | 37.99 |
| 200-Day Moving Average | 40.10 |
| Relative Strength Index (RSI) | 52.82 |
| Average Volume (20 Days) | 6,459 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6242 had revenue of TWD 589.21 million and earned 83.82 million in profits. Earnings per share was 2.62.
| Revenue | 589.21M |
| Gross Profit | 398.25M |
| Operating Income | 98.28M |
| Pretax Income | 104.05M |
| Net Income | 83.82M |
| EBITDA | 107.08M |
| EBIT | 98.28M |
| Earnings Per Share (EPS) | 2.62 |
Balance Sheet
The company has 190.22 million in cash and 126.02 million in debt, with a net cash position of 64.20 million or 2.02 per share.
| Cash & Cash Equivalents | 190.22M |
| Total Debt | 126.02M |
| Net Cash | 64.20M |
| Net Cash Per Share | 2.02 |
| Equity (Book Value) | 871.24M |
| Book Value Per Share | 27.39 |
| Working Capital | 84.59M |
Cash Flow
In the last 12 months, operating cash flow was 92.15 million and capital expenditures -329.38 million, giving a free cash flow of -237.23 million.
| Operating Cash Flow | 92.15M |
| Capital Expenditures | -329.38M |
| Depreciation & Amortization | 8.79M |
| Net Borrowing | 33.02M |
| Free Cash Flow | -237.23M |
| FCF Per Share | -7.46 |
Margins
Gross margin is 67.59%, with operating and profit margins of 16.68% and 14.23%.
| Gross Margin | 67.59% |
| Operating Margin | 16.68% |
| Pretax Margin | 17.66% |
| Profit Margin | 14.23% |
| EBITDA Margin | 18.17% |
| EBIT Margin | 16.68% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.26%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.26% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 75.89% |
| Buyback Yield | -2.50% |
| Shareholder Yield | 2.76% |
| Earnings Yield | 6.94% |
| FCF Yield | -19.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2023. It was a forward split with a ratio of 1.15.
| Last Split Date | Jun 30, 2023 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
TPEX:6242 has an Altman Z-Score of 4.97 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | 4 |